Cargando…

Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial

Objective. This clinical trial was designed to investigate whether goshajinkigan reduces the onset of diabetic complications or not. Materials and Methods. A total of 332 type 2 diabetic mellitus patients were registered from 9 clinical centers from March 2000 to August 2007. Patients were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, K., Shimada, A., Miyaki, K., Hirakata, A., Matsuoka, K., Omae, K., Takei, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000675/ https://www.ncbi.nlm.nih.gov/pubmed/24812564 http://dx.doi.org/10.1155/2014/128726

Ejemplares similares

Corrigendum to “Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial”
por: Watanabe, K., et al.
Publicado: (2016)

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
por: Kono, Toru, et al.
Publicado: (2013)

Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats
por: Kono, Toru, et al.
Publicado: (2015)

Novel Statistical Classification Model of Type 2 Diabetes Mellitus Patients for Tailor-made Prevention Using Data Mining Algorithm
por: Miyaki, Koichi, et al.
Publicado: (2007)

Drug-interaction between paclitaxel and goshajinkigan extract and its constituents
por: Nakayama, Akiko, et al.
Publicado: (2021)

Effects of Goshajinkigan, Hachimijiogan, and Rokumigan on Mechanical Allodynia Induced by Paclitaxel in Mice
por: Andoh, Tsugunobu, et al.
Publicado: (2014)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)

The effectiveness of traditional Japanese medicine Goshajinkigan in irradiation-induced aspermatogenesis in mice
por: Takahashi, Kumpei, et al.
Publicado: (2019)

Goshajinkigan attenuates paclitaxel‐induced neuropathic pain via cortical astrocytes
por: Takanashi, Kenta, et al.
Publicado: (2021)

Correction to: Drug-interaction between paclitaxel and goshajinkigan extract and its constituents
por: Nakayama, Akiko, et al.
Publicado: (2021)

Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel
por: Bahar, Muh. Akbar, et al.
Publicado: (2013)

Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
por: Kono, Toru, et al.
Publicado: (2011)

Behavioral and Immunohistochemical Evidence for Suppressive Effects of Goshajinkigan on Salicylate-Induced Tinnitus in Rats
por: Kitano, Koichi, et al.
Publicado: (2022)

Increased Risk of Obesity Resulting from the Interaction between High Energy Intake and the Trp64Arg Polymorphism of the β(3)-adrenergic Receptor Gene in Healthy Japanese Men
por: Miyaki, Koichi, et al.
Publicado: (2005)

Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2020)

An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi
por: Mizuno, Keita, et al.
Publicado: (2016)

The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action
por: Matsumura, Yukiko, et al.
Publicado: (2014)

Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula “Goshajinkigan”
por: Toume, Kazufumi, et al.
Publicado: (2019)

Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Correction to: Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula “Goshajinkigan”
por: Toume, Kazufumi, et al.
Publicado: (2020)

Safety of long-term use of linezolid: results of an open-label study
por: Vazquez, Jose A, et al.
Publicado: (2016)

Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results
por: Morita, Akimichi, et al.
Publicado: (2020)

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial
por: Ashina, Messoud, et al.
Publicado: (2023)

Long-term complications of the transmeatal approach (Open Transcanal) in cochlear implants: A follow-up study
por: Almofada, Hesham Saleh, et al.
Publicado: (2023)

Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study
por: Loomes, Kathleen M., et al.
Publicado: (2022)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
por: Kudrow, David, et al.
Publicado: (2021)

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
por: Riedl, Marc A., et al.
Publicado: (2017)

Goshajinkigan, a Traditional Japanese Medicine, Suppresses Voltage-Gated Sodium Channel Nav1.4 Currents in C2C12 Cells
por: Imai, Ryota, et al.
Publicado: (2020)

The Use of Transvenous Lead Extraction of Non-Infected Leads to Prevent Long-Term Lead-Related Complications
por: Ayvazyan, S.A., et al.
Publicado: (2021)

Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label Studies
por: Wish, Jay B., et al.
Publicado: (2019)

Foley Catheter for Induction of Labor at Term: An Open-Label, Randomized Controlled Trial
por: Gu, Ning, et al.
Publicado: (2015)

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial
por: Goll, G. L., et al.
Publicado: (2019)

Short-Term Safety Evaluation of a Multi-Pressure Dial: A Prospective, Open-label, Non-randomized Study
por: Thompson, Vance M., et al.
Publicado: (2019)

Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018)

Complications and satisfaction in transwomen receiving breast augmentation: short- and long-term outcomes
por: Schoffer, A. K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lis517b5bos3h859rhbmn2edh1